The ErbB4 Growth Factor Receptor Is Required for Colon Epithelial Cell Survival in the Presence of TNF

Gastroenterology

Volumn 136, Issue 1, 2009, Pages 217-226

  Frey, Mark R ^a   Edelblum, Karen L ^a   Mullane, Matthew T ^a   Liang, Dongchun ^a   Polk, D Brent ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B BETA; TUMOR NECROSIS FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; COLON CROHN DISEASE; COLON MUCOSA; ENTERITIS; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; COLON; CROHN DISEASE; CYTOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; CELL SURVIVAL; COLON; CROHN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 59849113041     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.09.023     Document Type: Article

References (43)

1. Carpenter G., and Cohen S. EGF: receptor interactions and the stimulation of cell growth. In: Lefkowitz R. (Ed). Receptors and recognition, Series B (1981), Chapman and Hall, London 43-66 Volume 13
2. Polk D.B. Epidermal growth factor receptor-stimulated intestinal epithelial cell migration requires phospholipase C activity. Gastroenterology 117 (1998) 493-502
3. Sinha A., Nightingale J., West K.P., et al. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med 349 (2003) 350-357
4. Plowman G.D., Culouscou J.-M., Whitney G.S., et al. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci U S A 90 (1993) 1746-1750
5. Long W., Wagner K.-U., Lloyd K.C.K., et al. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 130 (2003) 5257-5268
6. Vaskovsky A., Lupowitz Z., Erlich S., et al. ErbB-4 activation promotes neurite outgrowth in PC12 cells. J Neurochem 74 (2000) 979-987
7. Erlich S., Goldshmit Y., Lupowitz Z., et al. ErbB-4 activation inhibits apoptosis in PC12 cells. Neuroscience 107 (2001) 353-362
8. Kainulainen V., Sundvall M., Maatta J.A., et al. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis. J Biol Chem 275 (2000) 8641-8649
9. Tang C.K., Goldstein D.J., Payne J., et al. ErbB-4 ribozymes abolish neuregulin-induced mitogenesis. Cancer Res 58 (1998) 3415-3422
10. Ni C.Y., Murphy M.P., Golde T.E., et al. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294 (2001) 2179-2181
11. Linggi B., Cheng Q.C., Rao A.R., et al. The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase. Oncogene 25 (2006) 160-163
12. Komuro A., Nagai M., Navin N.E., et al. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxy-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 278 (2003) 33334-33341
13. Omerovic J., Puggioni E.M., Napoletano S., et al. Ligand-regulated association of ErbB-4 to the transcriptional co-activator YAP65 controls transcription at the nuclear level. Exp Cell Res 294 (2004) 469-479
14. Elenius K., Corfas G., Paul S., et al. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem 272 (1997) 26761-26768
15. Srinivasan R., Poulsom R., Hurst H.C., et al. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol 185 (1998) 236-245
16. Egger B., Procaccino F., Lakshmanan J., et al. Mice lacking transforming growth factor a have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology 113 (1997) 825-832
17. Egger B., Buchler M.W., Lakshmanan J., et al. Mice harboring a defective epidermal growth factor receptor (waved-2) have an increased susceptibility to acute dextran sulfate-induced colitis. Scand J Gastroenterol 35 (2000) 1181-1187
18. Wang J., and Fu Y.X. Tumor necrosis factor family members and inflammatory bowel disease. Immunol Rev 204 (2005) 144-155
19. Yan F., John S.K., and Polk D.B. Kinase suppressor of Ras determines survival of intestinal cells exposed to tumor necrosis factor. Cancer Res 61 (2001) 8668-8675
20. Kaiser G.C., and Polk D.B. Tumor necrosis factor α regulates proliferation in a mouse intestinal cell line. Gastroenterology 112 (1997) 1231-1240
21. Zwang Y., and Yarden Y. p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy. EMBO J 25 (2006) 4195-4206
22. Yan F., John S.K., Wilson G., et al. Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation. J Clin Invest 114 (2004) 1272-1280
23. Corredor J., Yan F., Shen C.S., et al. Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms. Am J Phys Cell Physiol 284 (2003) C953-C961
24. Egger B., Bajaj-Elliott M., MacDonald T.T., et al. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62 (2000) 240-248
25. Thommesen L., and Laegreid A. Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NFkappaB. J Biochem Mol Biol 38 (2005) 281-289
26. Schutze S., Potthoff K., Machleidt T., et al. TNF activates NFkB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphinomyelin breakdown. Cell 71 (1992) 765-776
27. Chen X., Levkowitz G., Tzahar E., et al. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4. J Biol Chem 271 (1996) 7620-7629
28. Li Z., Mei Y., Liu X., et al. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners. Cell Signal 19 (2007) 466-471
29. Chen W.N., Woodbury R.L., Kathmann L.E., et al. Induced autocrine signaling through the epidermal growth factor receptor contributes to the response of mammary epithelial cells to tumor necrosis factor alpha. J Biol Chem 279 (2004) 18488-18496
30. Argast G.M., Campbell J.S., Brooling J.T., et al. Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J Biol Chem 279 (2004) 34530-34536
31. Cheng Q.C., Tikhomirov O., Zhou W., et al. Ectodomain cleavage of ErbB-4: Characterization of the cleavage site and m80 fragment. J Biol Chem 278 (2003) 38421-38427
32. Mujoo K., Donato N.J., Lapushin R., et al. Tumor necrosis factor a and g-interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cells. J Immunol 13 (1993) 166-174
33. Schmiegel W., Roeder C., Schmielau J., et al. Tumor necrosis factor a induces the expression of transforming growth factor a and the epidermal growth factor receptor in human pancreatic cancer cells. Proc Natl Acad Sci U S A 90 (1993) 863-867
34. Palombella V.J., Yamashiro D.J., Maxfield F.R., et al. Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts. J Biol Chem 262 (1987) 1950-1954
35. Yamaoka T., Yan F., Cao H., et al. Transactivation of EGF receptor an ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proc Natl Acad Sci U S A 105 (2008) 11772-11777
36. Chen D., Xu L.G., Chen L., et al. NIK is a component of the EGF/heregulin receptor signaling complexes. Oncogene 22 (2003) 4348-4355
37. Zhu Y., Sullivan L.L., Nair S.S., et al. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells. Cancer Res 66 (2006) 7991-7998
38. Naresh A., Long W., Vidal G.A., et al. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Res 66 (2006) 6412-6420
39. Vidal G.A., Clark D.E., Marrero L., et al. A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities. Oncogene 26 (2007) 462-466
40. Anton E.S., Ghashghaei H.T., Weber J.L., et al. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci 7 (2004) 1319-1328
41. Fukata M., Chen A., Vamadevan A.S., et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133 (2007) 1869-1881
42. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126 (2004) 451-459
43. Jess T., Loftus Jr. E.V., Velayos F.S., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 130 (2006) 1039-1046